345 related articles for article (PubMed ID: 30376985)
1. CRISPR in personalized medicine: Industry perspectives in gene editing.
Hong A
Semin Perinatol; 2018 Dec; 42(8):501-507. PubMed ID: 30376985
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.
Mehta J
N Engl J Med; 2021 Jun; 384(23):e91. PubMed ID: 34107196
[No Abstract] [Full Text] [Related]
3. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.
Meisel R
N Engl J Med; 2021 Jun; 384(23):e91. PubMed ID: 34107195
[No Abstract] [Full Text] [Related]
4. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. Reply.
Frangoul H; Ho TW; Corbacioglu S
N Engl J Med; 2021 Jun; 384(23):e91. PubMed ID: 34107197
[No Abstract] [Full Text] [Related]
5. Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia.
Parums DV
Med Sci Monit; 2024 Mar; 30():e944204. PubMed ID: 38425279
[TBL] [Abstract][Full Text] [Related]
6. Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia.
Ye L; Wang J; Tan Y; Beyer AI; Xie F; Muench MO; Kan YW
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10661-5. PubMed ID: 27601644
[TBL] [Abstract][Full Text] [Related]
7. [Advances in gene therapy for β-thalassemia and hemophilia based on the CRISPR/Cas9 technology].
Bao LW; Zhou YY; Zeng FY
Yi Chuan; 2020 Oct; 42(10):949-964. PubMed ID: 33229321
[TBL] [Abstract][Full Text] [Related]
8. Tweaking genes with CRISPR or viruses fixes blood disorders.
Kaiser J
Science; 2020 Dec; 370(6522):1254-1255. PubMed ID: 33303593
[No Abstract] [Full Text] [Related]
9. Gene therapy for sickle cell disease.
The Lancet Haematology
Lancet Haematol; 2016 Oct; 3(10):e446. PubMed ID: 27692301
[No Abstract] [Full Text] [Related]
10. CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.
Frangoul H; Altshuler D; Cappellini MD; Chen YS; Domm J; Eustace BK; Foell J; de la Fuente J; Grupp S; Handgretinger R; Ho TW; Kattamis A; Kernytsky A; Lekstrom-Himes J; Li AM; Locatelli F; Mapara MY; de Montalembert M; Rondelli D; Sharma A; Sheth S; Soni S; Steinberg MH; Wall D; Yen A; Corbacioglu S
N Engl J Med; 2021 Jan; 384(3):252-260. PubMed ID: 33283989
[TBL] [Abstract][Full Text] [Related]
11. Promising Strategies for Sickle Cell Disease and β-Thalassemia.
Abbasi J
JAMA; 2021 Jan; 325(2):121. PubMed ID: 33433564
[No Abstract] [Full Text] [Related]
12. A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.
Cai L; Bai H; Mahairaki V; Gao Y; He C; Wen Y; Jin YC; Wang Y; Pan RL; Qasba A; Ye Z; Cheng L
Stem Cells Transl Med; 2018 Jan; 7(1):87-97. PubMed ID: 29164808
[TBL] [Abstract][Full Text] [Related]
13. CRISPR Advancements for Human Health.
Davis DJ; Yeddula SGR
Mo Med; 2024; 121(2):170-176. PubMed ID: 38694604
[TBL] [Abstract][Full Text] [Related]
14. Treatment of heritable diseases using CRISPR: Hopes, fears, and reality.
Kofler N; Kraschel KL
Semin Perinatol; 2018 Dec; 42(8):515-521. PubMed ID: 30420296
[TBL] [Abstract][Full Text] [Related]
15. CRISPR gene therapy shows promise against blood diseases.
Ledford H
Nature; 2020 Dec; 588(7838):383. PubMed ID: 33299166
[No Abstract] [Full Text] [Related]
16. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 gene-editing: Research technologies, clinical applications and ethical considerations.
Memi F; Ntokou A; Papangeli I
Semin Perinatol; 2018 Dec; 42(8):487-500. PubMed ID: 30482590
[TBL] [Abstract][Full Text] [Related]
18. UK first to approve CRISPR treatment for diseases: what you need to know.
Wong C
Nature; 2023 Nov; 623(7988):676-677. PubMed ID: 37974039
[No Abstract] [Full Text] [Related]
19. Enabling Precision Medicine with CRISPR-Cas Genome Editing Technology: A Translational Perspective.
Ilahibaks NF; Hulsbos MJ; Lei Z; Vader P; Sluijter JPG
Adv Exp Med Biol; 2023; 1396():315-339. PubMed ID: 36454475
[TBL] [Abstract][Full Text] [Related]
20. Engineered CRISPR Systems for Next Generation Gene Therapies.
Pineda M; Moghadam F; Ebrahimkhani MR; Kiani S
ACS Synth Biol; 2017 Sep; 6(9):1614-1626. PubMed ID: 28558198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
